Featured Research

from universities, journals, and other organizations

Inhalable measles vaccine tested

Date:
February 1, 2011
Source:
Johns Hopkins University Bloomberg School of Public Health
Summary:
Sustained high vaccination coverage is key to preventing deaths from measles. Despite the availability of a vaccine, measles remains an important killer of children worldwide, particularly in less-developed regions where vaccination coverage is limited. Researchers have developed and successfully tested a dry powder, live-attenuated measles vaccine that can be inhaled. The novel vaccine was studied in rhesus macaques.

Image of measles virus-infected cells.
Credit: Image courtesy of Johns Hopkins University Bloomberg School of Public Health

Sustained high vaccination coverage is key to preventing deaths from measles. Despite the availability of a vaccine, measles remains an important killer of children worldwide, particularly in less-developed regions where vaccination coverage is limited. A team of researchers, led by scientists at the Johns Hopkins Bloomberg School of Public Health and the University of Colorado, developed and successfully tested a dry powder, live-attenuated measles vaccine that can be inhaled. The novel vaccine was studied in rhesus macaques.

Results of the study are published in the January 31 edition of the journal PNAS.

The current measles vaccine requires two injections to provide full immunity -- one given at 9 to 12 months of age and another later in childhood. Special training for needle and syringe injections is needed to administer the vaccine, which requires refrigeration and is shipped as a powder that must be reconstituted and kept on ice in the field clinic. Such injections increase the risk of exposure to blood borne diseases.

According to the study, the new dry powder measles vaccine provided the macaques complete protection from measles with a single vaccine dose. The vaccine was delivered by aerosol using either one of two dry powder inhalers, the PuffHaler and the BD Solovent. No adverse effects were observed.

"An effective dry powder vaccine would be tremendously helpful in less developed regions where resources are limited," said Diane E. Griffin, MD, PhD, senior author of the study and chair of the W. Harry Feinstone Department of Molecular Microbiology and Immunology at the Bloomberg School of Public Health. "This vaccine can be shipped as powder and does not require reconstitution or special training to administer, which could greatly increase the ease and safety of measles vaccination worldwide."

Before a vaccine was developed in 1963, there were 130 million cases of measles each year resulting in more than 7 million deaths annually. Measles deaths were estimated to be 164,000 in 2008. Human trials for the dry powder measles vaccine are in development in India.

"The tests of inhalable dry powder vaccine at Johns Hopkins provide confidence that it can safely be tested in human volunteers after regulatory permission is given by Indian authorities," said Robert Sievers, professor at the CU Boulder and a Fellow of the Cooperative Institute of Research in Environmental Sciences. He is also CEO of Aktiv-Dry LLC and co-inventor of the PuffHaler and the new vaccine microparticles.

The research was supported by grants from the Bill & Melinda Gates Foundation and the Foundation for National Institutes of Health. Additional support was provided by the Marjorie Gilbert Scholarship Fund.


Story Source:

The above story is based on materials provided by Johns Hopkins University Bloomberg School of Public Health. Note: Materials may be edited for content and length.


Journal Reference:

  1. W.-H. Lin, D. E. Griffin, P. A. Rota, M. Papania, S. P. Cape, D. Bennett, B. Quinn, R. E. Sievers, C. Shermer, K. Powell, R. J. Adams, S. Godin, S. Winston. Successful respiratory immunization with dry powder live-attenuated measles virus vaccine in rhesus macaques. Proceedings of the National Academy of Sciences, 2011; DOI: 10.1073/pnas.1017334108

Cite This Page:

Johns Hopkins University Bloomberg School of Public Health. "Inhalable measles vaccine tested." ScienceDaily. ScienceDaily, 1 February 2011. <www.sciencedaily.com/releases/2011/02/110201122236.htm>.
Johns Hopkins University Bloomberg School of Public Health. (2011, February 1). Inhalable measles vaccine tested. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2011/02/110201122236.htm
Johns Hopkins University Bloomberg School of Public Health. "Inhalable measles vaccine tested." ScienceDaily. www.sciencedaily.com/releases/2011/02/110201122236.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
CDC Calls for New Ebola Safety Guidelines

CDC Calls for New Ebola Safety Guidelines

AP (Oct. 20, 2014) Centers for Disease Control and Prevention Director Dr. Tom Frieden laid out new guidelines for health care workers when dealing with the deadly Ebola virus including new precautions when taking off personal protective equipment. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins